The NICOLA Recruitment Trial (NICOLA-RT)

NCT ID: NCT01938898

Last Updated: 2018-04-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-01

Study Completion Date

2016-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA) is an opportunity to conduct methodology research relevant to many features of a large prospective study. NICOLA will begin in earnest in Northern Ireland in 2013 and is being conducted by a multidisciplinary team in the Centre for Public Health at Queen's University Belfast. It is an omnibus programme of research on ageing that will continue for at least 10 years and will recruit 8500 middle-aged people in Northern Ireland and follow them into old age, providing a comprehensive assessment of their physical and mental health, their lifestyles, and their social and economic decision making. NICOLA will look at how they perceive disability and health, and how this differs between well-off and disadvantaged groups. NICOLA will also study various genetic, biological and psychological factors, including how participants perceive risk and value their time, and the effect of this on their retirement behaviour (including how they manage their money and their health). People over the age of 50 will be invited to take part and asked to complete detailed interviews and questionnaires every 2 years and health assessments every 4 years.

The overall aim of this research is to examine the impact of differing invitation letters offered to participants on study recruitment rates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recruiting, retaining and gathering complete data on participants in research projects, be they patients or health professionals, can be extremely difficult. These problems increase the risk that research will be abandoned before its true value is appreciated, or lead to delays in resolving uncertainty for decision makers, while further studies are done. Poor recruitment, retention and outcome collection frequently lead to many prospective studies being extended, increasing costs. Researchers need to use strategies that are themselves evidence-based. This study links with an existing longitudinal ageing study called NICOLA to provide evidence on what research participants prefer in relation to providing personal information through a self-completed questionnaire. NICOLA is a large study of people over the age of 50 that is being conducted in Northern Ireland. NICOLA is aiming to recruit 8500 people and will ask them questions about participation in social activities, including organised structured and informal activities; relationship quality; loneliness; stress; resilience; quality of life; alcohol intake; food poverty and assess their health and wellbeing. Participants in NICOLA agree to having an interviewer visit them at home to ask questions about their lives, complete questionnaires in their own time and attend a health assessment appointment. They also agree to being followed up over a course of at least 10 years.

The research described here will examine the impact of differing invitation letters offered to participants on study recruitment rates, with the following specific objectives:

* Understanding if the gender of the person signing the invitation letter has an effect on recruitment
* Exploring the potential impact of the use of describing the research as a 'study' or as a 'project'
* Understanding if discussing and guaranteeing confidentiality for the participants in the invitation letter has an impact on recruitment.

We will do this by randomly allocating each of the 13000 participants contacted by NICOLA to receive invitation letter by one of the following three choices using a 3x2x2 factorial design:

1. Gender of the signatory (male versus female versus neutral team signature)
2. Description of NICOLA (study versus project)
3. Guarantee of confidentiality (inserted versus removed)

We will then analyse the numbers of participants agreeing to join NICOLA and use this to determine which invitation letter is the most acceptable to the participants. This research will occur within the first 18 months of NICOLA, when all participants are being recruited.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Cohort

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Potential NICOLA Participants

All potential participants identified through the sampling strategy and contacted to take part in the NICOLA study

Group Type OTHER

Invitation letter randomisation

Intervention Type OTHER

There are 12 versions of the invitation letter. Three aspects of the letter will be adapted: (1) Gender of the signatory i.e. male, female or gender neutral (signed from the NICOLA team) (2) Description of NICOLA as a 'study' or 'project' and (3) Inserting a sentence guaranteeing the participants confidentially or not having this in the letter (but will still appear in the Patient Information Sheet). The twelve versions are as follows:

1. Male \& Study \& Confidentiality
2. Male \& Study
3. Male \& Project \& Confidentiality
4. Male \& Project
5. Female \& Project \& Confidentiality
6. Female \& Project
7. Female \& Study \& Confidentiality
8. Female \& Study
9. Neutral \& Study \& Confidentiality
10. Neutral \& Study
11. Neutral \& Project \& Confidentiality
12. Neutral \& Project

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Invitation letter randomisation

There are 12 versions of the invitation letter. Three aspects of the letter will be adapted: (1) Gender of the signatory i.e. male, female or gender neutral (signed from the NICOLA team) (2) Description of NICOLA as a 'study' or 'project' and (3) Inserting a sentence guaranteeing the participants confidentially or not having this in the letter (but will still appear in the Patient Information Sheet). The twelve versions are as follows:

1. Male \& Study \& Confidentiality
2. Male \& Study
3. Male \& Project \& Confidentiality
4. Male \& Project
5. Female \& Project \& Confidentiality
6. Female \& Project
7. Female \& Study \& Confidentiality
8. Female \& Study
9. Neutral \& Study \& Confidentiality
10. Neutral \& Study
11. Neutral \& Project \& Confidentiality
12. Neutral \& Project

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must be aged 50 or over.
* Participants must be living in an non-institutionalised environment.
* Participants must be capable of providing informed consent.

Exclusion Criteria

* Participants who are 49 or younger.
* Participants who are institutionalised.
* Participants who are not capable of providing informed consent.
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Queen's University, Belfast

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lisa Maguire

Research Fellow

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mike Clarke, PhD

Role: PRINCIPAL_INVESTIGATOR

Queen's University, Belfast

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lisa Maguire

Belfast, Northern Ireland, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

12/23

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Quebec Lung Cancer Screening PLUS Trial
NCT05444062 ACTIVE_NOT_RECRUITING NA
Which Automated Methodology?
NCT06049056 COMPLETED